Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · IEX Real-Time Price · USD
26.00
+0.17 (0.66%)
At close: May 2, 2024, 4:00 PM
25.50
-0.50 (-1.92%)
After-hours: May 2, 2024, 4:51 PM EDT
Dyne Therapeutics Employees
Dyne Therapeutics had 123 employees on December 31, 2022. The number of employees increased by 28 or 29.47% compared to the previous year.
Employees
123
Change (1Y)
28
Growth (1Y)
29.47%
Revenue / Employee
n/a
Profits / Employee
-$1,918,187
Market Cap
2.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 123 | 28 | 29.47% |
Dec 31, 2021 | 95 | 48 | 102.13% |
Dec 31, 2020 | 47 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
CONMED | 4,000 |
Amphastar Pharmaceuticals | 1,761 |
Intellia Therapeutics | 526 |
Deciphera Pharmaceuticals | 355 |
Sana Biotechnology | 328 |
Rocket Pharmaceuticals | 268 |
TG Therapeutics | 264 |
Kymera Therapeutics | 187 |
DYN News
- 4 hours ago - Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer - GlobeNewsWire
- 5 weeks ago - Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium - GlobeNewsWire
- 5 weeks ago - Dyne Therapeutics Announces CEO Transition - GlobeNewsWire
- 7 weeks ago - Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days - GlobeNewsWire
- 2 months ago - Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference - GlobeNewsWire
- 3 months ago - Dyne Therapeutics to Present at February Investor Conferences - GlobeNewsWire